 In a recent study comparing Trusopt with Xalatan some very encouraging results emerged, AVP time was significantly reduced with Trusopt, but not with Xalatan despite the fact that Xalatan increases perfusion pressure due to IOP more than Trusopt. This is the strongest evidence so far of a pressure independent effect of Trusopt on ocular blood flow. 